-
Patient Care,
Translational Medicine
New drugs to treat bladder, endometrial, and non-small cell lung cancer and melanoma were approved.
-
Patient Care,
In the Media,
Translational Medicine
Dr. Faith E. Davies discusses the approval of second CAR T-cell therapy for multiple myeloma.
-
Research,
Patient Care,
Translational Medicine
People receive world-class care at Long Island’s only full-service NCI-designated Comprehensive Cancer Center.
-
Patient Care,
Translational Medicine
Dr. Nancy Chan selects clinical trials that best serve the diverse patient population.
-
Patient Care,
Translational Medicine,
Press Releases
Dr. Faith E. Davies will oversee development of a biospecimens resource for research on blood cancers.
-
Research,
Patient Care,
Translational Medicine
The therapy is a potential game changer for treating this common form of bladder cancer.
-
Research,
Translational Medicine,
Press Releases
Study shows that new combination of drugs is safe and effective in helping stem cell transplantation.
-
Research,
Patient Care,
Translational Medicine
An octogenarian beats back prostate cancer with a bold treatment plan at Perlmutter Cancer Center.
Perlmutter Cancer Center Magazine, Fall 2021
-
Patient Care,
In the Media,
Translational Medicine
Identifying the mutation type in HER2-positive non-small cell lung cancer helps select the best treatment.
-
Patient Care,
In the Media,
Translational Medicine
Lung cancer clinical trials at Perlmutter Cancer Center improve outlooks and life expectancy.